Skip to main content
. 2016 Jul 15;6:29765. doi: 10.1038/srep29765

Table 5. Median survival (months) and multivariable HR for death after diagnosis of metastatic (M1) colorectal cancer, by sex, primary site, histological subtype, age at diagnosis, stage, and metastatic site.

Characteristic N HR 95% CI Median survival (months)
Total 3379       9
Sex
Men 1902 1 1 1 10
Women 1477 1.01 0.93 1.09 8
Age at diagnosis
<60 673 1 1 1 12
60–69 1011 1.09 0.97 1.23 11
70–79 1007 1.60 1.43 1.80 8
>79 688 2.40 2.12 2.72 5
T stage
T1 35 1.38 0.91 2.11 10
T2 90 0.63 0.47 0.85 16.5
T3 1331 1 1 1 13
T4 933 1.53 1.39 1.70 8
TX 930 2.07 1.77 2.42 5
N stage
N0 476 1 1 1 19
N1 710 1.52 1.31 1.77 13
N2 1113 2.09 1.82 2.40 8
NX 1080 2.23 1.87 2.65 5
Metastatic site
Thorax 220 0.64 0.55 0.76 14
Peritoneum 271 0.81 0.70 0.95 7
Liver 2643 1 1 1 9
Gastro-intestinal 48 0.72 0.53 0.99 6.5
Bone 42 1.56 1.13 2.16 5.5
Nervous system 32 1.73 1.21 2.49 4
Other 123 0.87 0.71 1.07 9
Anatomical site
Proximal colon 1051 1.42 1.29 1.56 6
Distal colon 1202 0.96 0.87 1.07 11
Rectum 1126 1 1 1 11
Histological subtype
Adenocarcinoma 3153 1 1 1 9
Signet ring/Mucinous 226 0.83 0.70 0.98 10

Only patients with one distant metastasis are included.

Bold values indicate significantly higher hazard, and underlined values indicate significantly lower hazard.